Category: 2024

Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) reminds investors that a complaint has been filed on behalf of purchasers or acquirers of Checkpoint Therapeutics, Inc. (“Checkpoint” or the “Company”) (NASDAQ: CKPT) securities between March 10, 2021 and December 15, 2023 (the “Class Period”).  Click Here to Join Investigation. …

Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of The Chemours Company (“Chemours” or the “Company”)(NYSE: CC). Click Here To Join Investigation….

Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) reminds investors that a complaint has been filed on behalf of purchasers or acquirers of the common stock of Doximity, Inc. (“Doximity” or the “Company”) (NYSE: DOCS) between February 9, 2022 and April 1, 2024 (the “Class Period”)….

Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of Vestis Corporation (“Vestis” or the “Company”) (NYSE: VSTS)….

Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of PowerSchool Holdings, Inc. (“PowerSchool” or the “Company”)(NYSE: PWSC).  Click Here To Join The Investigation….

Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of Jabil Inc. (“Jabil” or the “Company”)(NYSE: JBL).  Click Here To Join The Investigation….

Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of Zoetis Inc.  (“Zoetis” or the “Company”)(NYSE: ZTS).  Click here to join the investigation….

Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of the purchasers of UNI tokens from Uniswap Labs (“Uniswap”). Click here to join the investigation….